Qvella Corporation Stock
Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology.
Sign up today and learn more about Qvella Corporation Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Qvella Corporation Stock
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.
Funding History
March 2015 | $2.0M |
---|---|
October 2015 | $20.0M |
December 2017 | $25.0M |
Management
President and CEO
Tino Alavie
Chief Scientist
Samad Talebpour
Vice President
Robert Maaskant
Senior Scientist
Aye Aye Khine
Press
patents - Apr, 14 2024
Apparatus, system and method for performing automated centrifugal separationpatents - Apr, 14 2024
Apparatus and method for pretreatment of microbial samplespatents - Apr, 14 2024
Methods of performing nucleic acid stabilization and separationpatents - Apr, 14 2024
Systems and methods for classification of microbial cells grown in …patents - Apr, 14 2024
Methods of targeted antibiotic susceptibility testing